保护科学诚信和针对COVID-19的公共政策声明

Q2 Decision Sciences

Advances in Decision Sciences Pub Date : 2020-01-01 DOI:10.47654/v24y2020i1p70-84

M. McAleer

{"title":"保护科学诚信和针对COVID-19的公共政策声明","authors":"M. McAleer","doi":"10.47654/v24y2020i1p70-84","DOIUrl":null,"url":null,"abstract":"The SARS-CoV-2 virus and the associated COVID-19 disease is a pandemic that has rocked the world in terms of public health and medical issues, business, economics and finance. Interesting and topical discussions regarding risk management of COVID-19 have been reported in leading business, economics, finance, and medical journals, as well as information and misinformation, intended or not, in the mass media. In this context, protecting the integrity of public policy pronouncements relating to the conduct and outcomes of scientific clinical trials. In terms of protecting the scientific integrity of clinical trials of COVID-19 patients, it is intentional to determine whether imperfectly collected data on clinical trials are more useful than having no data at all.","PeriodicalId":38875,"journal":{"name":"Advances in Decision Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Protecting Scientific Integrity and Public Policy Pronouncements on COVID-19\",\"authors\":\"M. McAleer\",\"doi\":\"10.47654/v24y2020i1p70-84\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The SARS-CoV-2 virus and the associated COVID-19 disease is a pandemic that has rocked the world in terms of public health and medical issues, business, economics and finance. Interesting and topical discussions regarding risk management of COVID-19 have been reported in leading business, economics, finance, and medical journals, as well as information and misinformation, intended or not, in the mass media. In this context, protecting the integrity of public policy pronouncements relating to the conduct and outcomes of scientific clinical trials. In terms of protecting the scientific integrity of clinical trials of COVID-19 patients, it is intentional to determine whether imperfectly collected data on clinical trials are more useful than having no data at all.\",\"PeriodicalId\":38875,\"journal\":{\"name\":\"Advances in Decision Sciences\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Decision Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47654/v24y2020i1p70-84\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Decision Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Decision Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47654/v24y2020i1p70-84","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Decision Sciences","Score":null,"Total":0}

引用次数: 1

摘要

SARS-CoV-2病毒及其相关的COVID-19疾病是一场在公共卫生和医疗问题、商业、经济和金融方面震撼世界的大流行。主要的商业、经济、金融和医学期刊报道了关于COVID-19风险管理的有趣和热门讨论，大众媒体也报道了有意或无意的信息和错误信息。在此背景下，保护与科学临床试验的行为和结果有关的公共政策声明的完整性。在保护新冠肺炎患者临床试验的科学完整性方面，有意确定收集不完整的临床试验数据是否比完全没有数据更有用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Protecting Scientific Integrity and Public Policy Pronouncements on COVID-19

The SARS-CoV-2 virus and the associated COVID-19 disease is a pandemic that has rocked the world in terms of public health and medical issues, business, economics and finance. Interesting and topical discussions regarding risk management of COVID-19 have been reported in leading business, economics, finance, and medical journals, as well as information and misinformation, intended or not, in the mass media. In this context, protecting the integrity of public policy pronouncements relating to the conduct and outcomes of scientific clinical trials. In terms of protecting the scientific integrity of clinical trials of COVID-19 patients, it is intentional to determine whether imperfectly collected data on clinical trials are more useful than having no data at all.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advances in Decision Sciences Mathematics-Applied Mathematics

CiteScore

4.70

自引率

0.00%

发文量

审稿时长

29 weeks